Ellen Marin

Honored to have accepted the Scholarly Impact Award of Advanced Practice at Emory #Emory #EmoryAPP

I am so honored to have received Emory’s APP Scholarly Impact award. I will continue to fulfill this legacy to push myself, colleagues, and profession forward

In data we trust

Thank you to everyone who came to the 4th Annual Updates in Oncology conference! It was one of the best years yet. It would not have been possible without our amazing speakers and the WCI APP Education Committee. Now time to make next year even better

Day 2 of Updates in Oncology conference - the hematology session - with an amazing line up of speakers. World T-Cell expert @MaryjoLechowicz and Myeloma leader @SagarLonialMD followed by our clinical pharmacy specialists and finishing with the longtime leukemia APP Angela Hatcher

I am honored to have received the Charise Gleason Excellence in Oncology Education Award — A testament to my commitment to life long learning

Day 1 of the 4th annual Updates in Oncology conference hosted by the WCI APP Education Committee — a great day starting with TIL, Sickle Cell, Pain Management Panel and finishing off with HLH!

Highlights of Olympic swimming so far have been seeing @katieledecky get an OR and @leonmarchand win gold for France while competing in France - all really cool things to watch

@katieledecky is the most dominant female swimmer of all time. Prove me wrong #GOAT

Malignant Heme Team 🩸

Our team is hiring! NP or PA, Inpatient Malignant Hematology, Emory University Hospital (#Atlanta, Georgia) #job social.icims.com/viewjob/pt1715…

@EagleMyeloma Preach!

Dr. Stadtmauer reviews #myeloma induction, clarifies the strong foundation of Dara+Rd in frail patients, and expertly discusses the good & bad of Dara as part of induction. Tragic that Perseus didn't have a second randomization at maintenance. #mmsm nejm.org/doi/10.1056/NE…

In a bowl of apples when one goes bad, the rest will quickly follow.

Inpatient Malignant Heme Christmas Crew! @WinshipAtEmory

Excited to share our experience with prophylactic tocilizumab for prevention of teclistamab associated CRS! @EMarinPA_C ⁦@BloodCancerJnl⁩ nature.com/articles/s4140…

@sarahwyman12 Thank you Sarah! Your constant support means so much

Couldn’t be prouder 🙌

Excited to share our fresh off the press manuscript in BCJ: Prophylactic tocilizumab to prevent cytokine release syndrome (CRS) with teclistamab: A single-center experience | Blood Cancer Journal ⁦@WinshipAtEmory ⁦@saraann9⁩ nature.com/articles/s4140…

#ASH23 Marathon training

Poster session yesterday at #ASH23 was a big success! Thank you to everyone that attended our poster 🙌🏼 @AjayNookaMD @saraann9 @WinshipAtEmory

Amazing to be able to work with so many people who are able to continue to push the field forward #ASH23 @WinshipAtEmory